| Name | Title | Contact Details |
|---|
Cellerant Therapeutics is a clinical stage biotechnology company focused on developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant`s programs include: CLT-008, an off-the-shelf cellular immunotherapy, under evaluation in a multicenter, open-label, randomized, controlled Phase 2 clinical trial in patients with de novo AML; CSC030-ADC, a preclinical monoclonal antibody drug conjugate that selectively targets and kills leukemic stem and blast cells responsible for initiating and maintaining disease; and CSC012, a preclinical monoclonal antibody targeting leukemic and pre-leukemic stem cells for acute leukemias and myelodysplastic syndromes. The Company is also developing next generation CAR product candidates leveraging its proprietary immunocellular therapy and antibody discovery and development platform.
Capstone Logistics is the leader in providing specialized, technology-enabled solutions for the most challenging supply chains. Powered by an interconnected platform, Capstone creates end-to-end efficiencies and cost-savings that help suppliers, distributers, and retailers exceed customer expectations. From performance-driven labor solutions to high-touch transportation and fulfillment, Capstone delivers the scale, accountability, and continuity that enables modern supply chains to compete in an ever-evolving environment.
Pinchevsky and Co is a Burnaby, BC-based company in the Business Services sector.
Schneider Associates is a Boston, MA-based company in the Business Services sector.
BayHawk Capital is a Boston-based private equity firm dedicated to driving growth in lower middle market technology and services companies, investing $20 to $125 million of equity per opportunity. Our hands-on approach, combined with a track record of successful investments and value creation, positions us as a trusted partner for companies seeking to scale and thrive in todays competitive landscape.